Department: Biomedical Sciences
University: Ulster University
Country: United Kingdom
Professor Tara Moore, PhD and Harvard graduate with a wealth of experience of working in Universities and laboratories across UK, Europe and USA has made tremendous advances in progressing novel diagnosis and treatment for blinding eye diseases helping new research findings translate toward the clinic and patients in a personalized medicine approach. She is Director of Biomedical Sciences Research Institute, Ulster University and has direct line management responsibility for over 130 staff and researchers and over 120 PhDs within the research institute.
The culmination of Professor Moore’s contribution to health, well-being and safety and improving people’s lives whilst inspiring others to see the opportunities to make a difference through science was recognised with the prestigious WISE award presented by HRH Princess Anne and most recently a prestigious Winston Churchill Fellowship.
Her research interest, mainly focuses on developing siRNA and CRISPR-Cas9 for the cornea paving the way for gene silencing and gene editing in corneal dystrophies, developing remarkably potent mutant allele specific siRNAs and PAM specific CRISPR-Cas9 technologies.
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: email@example.com
Copyright © 2020 Boffin Access Limited.